Publicações

Efficacy, Pharmacokinetics, and Safety of the Biosimilar Ct-P10 in Comparison with Rituximab in Patients with Previously Untreated Low-Tumour-Burden Follicular Lymphoma: a Randomised, Double-Blind, Parallel-Group, Phase 3 Trial

AuthID
P-00P-TAH

Author(s)

Ogura, M

Sancho, JM

Cho, SG

Nakazawa, H

Suzumiya, J

Tumyan, G

Kim, JS

Lennard, A

[+3]·

[+1]·

Popplewell, L

Buske, C

Kim, WS

Lee, SJ

Lee, SY

Bae, YJ

Kwak, LW

View all authors

Tipo de Documento

Article

Year published

2018

Publicado

in LANCET HAEMATOLOGY, ISSN: 2352-3026

Volume: 5, Número: 11, Páginas: E543-E553 (11)

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1016/s2352-3026(18)30157-1

Pubmed: 30389036

SCOPUS: 2-s2.0-85055626864

Wos: WOS:000448842300014

Source Identifiers

ISSN: 2352-3026

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Nome	Name Order	Nome	Name Order	Nome
1	Ogura, M;	2	Sancho, JM;	3	Cho, SG;
4	Nakazawa, H;	5	Suzumiya, J;	6	Tumyan, G;
7	Kim, JS;	8	Lennard, A;	9	Mariz, J;
10	Ilyin, N;	11	Jurczak, W;	12	Martinez, AL;
13	Samoilova, O;	14	Zhavrid, E;	15	Ruiz, EY;
16	Trneny, M;	17	Popplewell, L;	18	Coiffier, B;
19	Buske, C;	20	Kim, WS;	21	Lee, SJ;
22	Lee, SY;	23	Bae, YJ;	24	Kwak, LW;

Efficacy, Pharmacokinetics, and Safety of the Biosimilar Ct-P10 in Comparison with Rituximab in Patients with Previously Untreated Low-Tumour-Burden Follicular Lymphoma: a Randomised, Double-Blind, Parallel-Group, Phase 3 Trial

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Efficacy, Pharmacokinetics, and Safety of the Biosimilar Ct-P10 in Comparison with Rituximab in Patients with Previously Untreated Low-Tumour-Burden Follicular Lymphoma: a Randomised, Double-Blind, Parallel-Group, Phase 3 Trial

Links Úteis

Ajuda